Are Salivary Gland Ultrasonography Scores Associated with Salivary Flow Rates and Oral Health-related Quality of Life in Sjögren Syndrome?
Identifieur interne : 000050 ( Main/Exploration ); précédent : 000049; suivant : 000051Are Salivary Gland Ultrasonography Scores Associated with Salivary Flow Rates and Oral Health-related Quality of Life in Sjögren Syndrome?
Auteurs : Yasemin Yalcinkaya [Turquie] ; Gonca Mumcu [Turquie] ; Filiz Türe Özdemir [Turquie] ; Ramazan Esad Kuru [Turquie] ; Ali U Ur Ünal [Turquie] ; Haner Direskeneli [Turquie] ; George A. Bruyn [Pays-Bas] ; Nevsun Inanc [Oman]Source :
- The Journal of rheumatology [ 0315-162X ] ; 2020.
Descripteurs français
- KwdFr :
- MESH :
- imagerie diagnostique : Glandes salivaires.
- métabolisme : Salive.
- Humains, Indice de gravité de la maladie, Qualité de vie, Syndrome de Gougerot-Sjögren, Échographie.
English descriptors
- KwdEn :
- MESH :
- diagnostic imaging : Salivary Glands.
- metabolism : Saliva.
- Humans, Quality of Life, Severity of Illness Index, Sjogren's Syndrome, Ultrasonography.
Abstract
OBJECTIVE
Major salivary gland ultrasonography (SGUS) is a widely used imaging technique to evaluate salivary gland involvement in primary Sjögren syndrome (pSS). The aim of this study was to evaluate the relationship between SGUS, salivary flow rate (SFR) as an objective measure of the gland function, and oral health-related quality of life (OHRQOL) as a patient-reported outcome measure (PROM) in a pSS cohort.
METHODS
Sixty-six patients with pSS were examined by SGUS according to Hocevar and Milic scoring systems. Patients with inhomogeneity/hypoechoic areas with scores ≥ 2 in parotid and submandibular glands were classified separately as "severe glandular involvement." Further, oral health, SFR, and Oral Health Impact Profile-14 (OHIP-14) for OHRQOL were assessed.
RESULTS
Both total Hocevar and Milic scores were higher in 21 pSS patients with low unstimulated whole salivary flow rate (U-WSFR) than 45 pSS patients without low U-WSFR (
CONCLUSION
High Milic and Hocevar SGUS scores are associated with reduced SFR and poor OHRQOL as a PROM. The inhomogeneity component of the SGUS score is associated with low U-WSFR and is an indicator of severely affected gland function.
DOI: 10.3899/jrheum.190849
PubMed: 32358157
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Are Salivary Gland Ultrasonography Scores Associated with Salivary Flow Rates and Oral Health-related Quality of Life in Sjögren Syndrome?</title><author><name sortKey="Yalcinkaya, Yasemin" sort="Yalcinkaya, Yasemin" uniqKey="Yalcinkaya Y" first="Yasemin" last="Yalcinkaya">Yasemin Yalcinkaya</name><affiliation wicri:level="1"><nlm:affiliation>Y. Yalcinkaya, Associate Professor, A. U. Ünal, MD, H. Direskeneli, Professor, N. Inanc, Professor, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Y. Yalcinkaya, Associate Professor, A. U. Ünal, MD, H. Direskeneli, Professor, N. Inanc, Professor, Division of Rheumatology, Marmara University, School of Medicine, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Mumcu, Gonca" sort="Mumcu, Gonca" uniqKey="Mumcu G" first="Gonca" last="Mumcu">Gonca Mumcu</name><affiliation wicri:level="1"><nlm:affiliation>G. Mumcu, Dentist, Professor, Department of Health Management, Marmara University School of Health Sciences, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>G. Mumcu, Dentist, Professor, Department of Health Management, Marmara University School of Health Sciences, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Ozdemir, Filiz Ture" sort="Ozdemir, Filiz Ture" uniqKey="Ozdemir F" first="Filiz Türe" last="Özdemir">Filiz Türe Özdemir</name><affiliation wicri:level="1"><nlm:affiliation>F. Türe Özdemir, PhD, Division of Immunology, Marmara University, School of Medicine, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>F. Türe Özdemir, PhD, Division of Immunology, Marmara University, School of Medicine, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Kuru, Ramazan Esad" sort="Kuru, Ramazan Esad" uniqKey="Kuru R" first="Ramazan Esad" last="Kuru">Ramazan Esad Kuru</name><affiliation wicri:level="1"><nlm:affiliation>R. Esad Kuruş, MD, Marmara University, School of Medicine, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>R. Esad Kuruş, MD, Marmara University, School of Medicine, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Unal, Ali U Ur" sort="Unal, Ali U Ur" uniqKey="Unal A" first="Ali U Ur" last="Ünal">Ali U Ur Ünal</name><affiliation wicri:level="1"><nlm:affiliation>Y. Yalcinkaya, Associate Professor, A. U. Ünal, MD, H. Direskeneli, Professor, N. Inanc, Professor, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Y. Yalcinkaya, Associate Professor, A. U. Ünal, MD, H. Direskeneli, Professor, N. Inanc, Professor, Division of Rheumatology, Marmara University, School of Medicine, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Direskeneli, Haner" sort="Direskeneli, Haner" uniqKey="Direskeneli H" first="Haner" last="Direskeneli">Haner Direskeneli</name><affiliation wicri:level="1"><nlm:affiliation>Y. Yalcinkaya, Associate Professor, A. U. Ünal, MD, H. Direskeneli, Professor, N. Inanc, Professor, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Y. Yalcinkaya, Associate Professor, A. U. Ünal, MD, H. Direskeneli, Professor, N. Inanc, Professor, Division of Rheumatology, Marmara University, School of Medicine, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Bruyn, George A" sort="Bruyn, George A" uniqKey="Bruyn G" first="George A" last="Bruyn">George A. Bruyn</name><affiliation wicri:level="1"><nlm:affiliation>G.A. Bruyn, Professor, Department of Rheumatology, MC Groep Hospitals, Leystad, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>G.A. Bruyn, Professor, Department of Rheumatology, MC Groep Hospitals, Leystad</wicri:regionArea><wicri:noRegion>Leystad</wicri:noRegion></affiliation></author><author><name sortKey="Inanc, Nevsun" sort="Inanc, Nevsun" uniqKey="Inanc N" first="Nevsun" last="Inanc">Nevsun Inanc</name><affiliation wicri:level="1"><nlm:affiliation>Y. Yalcinkaya, Associate Professor, A. U. Ünal, MD, H. Direskeneli, Professor, N. Inanc, Professor, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey; inanc.nevsun@gmail.com.</nlm:affiliation><country wicri:rule="url">Oman</country><wicri:regionArea>Y. Yalcinkaya, Associate Professor, A. U. Ünal, MD, H. Direskeneli, Professor, N. Inanc, Professor, Division of Rheumatology, Marmara University, School of Medicine, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32358157</idno><idno type="pmid">32358157</idno><idno type="doi">10.3899/jrheum.190849</idno><idno type="wicri:Area/Main/Corpus">000037</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000037</idno><idno type="wicri:Area/Main/Curation">000037</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000037</idno><idno type="wicri:Area/Main/Exploration">000037</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Are Salivary Gland Ultrasonography Scores Associated with Salivary Flow Rates and Oral Health-related Quality of Life in Sjögren Syndrome?</title><author><name sortKey="Yalcinkaya, Yasemin" sort="Yalcinkaya, Yasemin" uniqKey="Yalcinkaya Y" first="Yasemin" last="Yalcinkaya">Yasemin Yalcinkaya</name><affiliation wicri:level="1"><nlm:affiliation>Y. Yalcinkaya, Associate Professor, A. U. Ünal, MD, H. Direskeneli, Professor, N. Inanc, Professor, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Y. Yalcinkaya, Associate Professor, A. U. Ünal, MD, H. Direskeneli, Professor, N. Inanc, Professor, Division of Rheumatology, Marmara University, School of Medicine, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Mumcu, Gonca" sort="Mumcu, Gonca" uniqKey="Mumcu G" first="Gonca" last="Mumcu">Gonca Mumcu</name><affiliation wicri:level="1"><nlm:affiliation>G. Mumcu, Dentist, Professor, Department of Health Management, Marmara University School of Health Sciences, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>G. Mumcu, Dentist, Professor, Department of Health Management, Marmara University School of Health Sciences, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Ozdemir, Filiz Ture" sort="Ozdemir, Filiz Ture" uniqKey="Ozdemir F" first="Filiz Türe" last="Özdemir">Filiz Türe Özdemir</name><affiliation wicri:level="1"><nlm:affiliation>F. Türe Özdemir, PhD, Division of Immunology, Marmara University, School of Medicine, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>F. Türe Özdemir, PhD, Division of Immunology, Marmara University, School of Medicine, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Kuru, Ramazan Esad" sort="Kuru, Ramazan Esad" uniqKey="Kuru R" first="Ramazan Esad" last="Kuru">Ramazan Esad Kuru</name><affiliation wicri:level="1"><nlm:affiliation>R. Esad Kuruş, MD, Marmara University, School of Medicine, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>R. Esad Kuruş, MD, Marmara University, School of Medicine, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Unal, Ali U Ur" sort="Unal, Ali U Ur" uniqKey="Unal A" first="Ali U Ur" last="Ünal">Ali U Ur Ünal</name><affiliation wicri:level="1"><nlm:affiliation>Y. Yalcinkaya, Associate Professor, A. U. Ünal, MD, H. Direskeneli, Professor, N. Inanc, Professor, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Y. Yalcinkaya, Associate Professor, A. U. Ünal, MD, H. Direskeneli, Professor, N. Inanc, Professor, Division of Rheumatology, Marmara University, School of Medicine, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Direskeneli, Haner" sort="Direskeneli, Haner" uniqKey="Direskeneli H" first="Haner" last="Direskeneli">Haner Direskeneli</name><affiliation wicri:level="1"><nlm:affiliation>Y. Yalcinkaya, Associate Professor, A. U. Ünal, MD, H. Direskeneli, Professor, N. Inanc, Professor, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Y. Yalcinkaya, Associate Professor, A. U. Ünal, MD, H. Direskeneli, Professor, N. Inanc, Professor, Division of Rheumatology, Marmara University, School of Medicine, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author><author><name sortKey="Bruyn, George A" sort="Bruyn, George A" uniqKey="Bruyn G" first="George A" last="Bruyn">George A. Bruyn</name><affiliation wicri:level="1"><nlm:affiliation>G.A. Bruyn, Professor, Department of Rheumatology, MC Groep Hospitals, Leystad, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>G.A. Bruyn, Professor, Department of Rheumatology, MC Groep Hospitals, Leystad</wicri:regionArea><wicri:noRegion>Leystad</wicri:noRegion></affiliation></author><author><name sortKey="Inanc, Nevsun" sort="Inanc, Nevsun" uniqKey="Inanc N" first="Nevsun" last="Inanc">Nevsun Inanc</name><affiliation wicri:level="1"><nlm:affiliation>Y. Yalcinkaya, Associate Professor, A. U. Ünal, MD, H. Direskeneli, Professor, N. Inanc, Professor, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey; inanc.nevsun@gmail.com.</nlm:affiliation><country wicri:rule="url">Oman</country><wicri:regionArea>Y. Yalcinkaya, Associate Professor, A. U. Ünal, MD, H. Direskeneli, Professor, N. Inanc, Professor, Division of Rheumatology, Marmara University, School of Medicine, Istanbul</wicri:regionArea><wicri:noRegion>Istanbul</wicri:noRegion></affiliation></author></analytic><series><title level="j">The Journal of rheumatology</title><idno type="ISSN">0315-162X</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Humans (MeSH)</term><term>Quality of Life (MeSH)</term><term>Saliva (metabolism)</term><term>Salivary Glands (diagnostic imaging)</term><term>Severity of Illness Index (MeSH)</term><term>Sjogren's Syndrome (MeSH)</term><term>Ultrasonography (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Glandes salivaires (imagerie diagnostique)</term><term>Humains (MeSH)</term><term>Indice de gravité de la maladie (MeSH)</term><term>Qualité de vie (MeSH)</term><term>Salive (métabolisme)</term><term>Syndrome de Gougerot-Sjögren (MeSH)</term><term>Échographie (MeSH)</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Salivary Glands</term></keywords><keywords scheme="MESH" qualifier="imagerie diagnostique" xml:lang="fr"><term>Glandes salivaires</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Saliva</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Salive</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Quality of Life</term><term>Severity of Illness Index</term><term>Sjogren's Syndrome</term><term>Ultrasonography</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Humains</term><term>Indice de gravité de la maladie</term><term>Qualité de vie</term><term>Syndrome de Gougerot-Sjögren</term><term>Échographie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>OBJECTIVE</b></p><p>Major salivary gland ultrasonography (SGUS) is a widely used imaging technique to evaluate salivary gland involvement in primary Sjögren syndrome (pSS). The aim of this study was to evaluate the relationship between SGUS, salivary flow rate (SFR) as an objective measure of the gland function, and oral health-related quality of life (OHRQOL) as a patient-reported outcome measure (PROM) in a pSS cohort.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>Sixty-six patients with pSS were examined by SGUS according to Hocevar and Milic scoring systems. Patients with inhomogeneity/hypoechoic areas with scores ≥ 2 in parotid and submandibular glands were classified separately as "severe glandular involvement." Further, oral health, SFR, and Oral Health Impact Profile-14 (OHIP-14) for OHRQOL were assessed.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Both total Hocevar and Milic scores were higher in 21 pSS patients with low unstimulated whole salivary flow rate (U-WSFR) than 45 pSS patients without low U-WSFR (</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSION</b></p><p>High Milic and Hocevar SGUS scores are associated with reduced SFR and poor OHRQOL as a PROM. The inhomogeneity component of the SGUS score is associated with low U-WSFR and is an indicator of severely affected gland function.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">32358157</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0315-162X</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>12</Issue><PubDate><Year>2020</Year><Month>12</Month><Day>01</Day></PubDate></JournalIssue><Title>The Journal of rheumatology</Title><ISOAbbreviation>J Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Are Salivary Gland Ultrasonography Scores Associated with Salivary Flow Rates and Oral Health-related Quality of Life in Sjögren Syndrome?</ArticleTitle><Pagination><MedlinePgn>1774-1779</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3899/jrheum.190849</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Major salivary gland ultrasonography (SGUS) is a widely used imaging technique to evaluate salivary gland involvement in primary Sjögren syndrome (pSS). The aim of this study was to evaluate the relationship between SGUS, salivary flow rate (SFR) as an objective measure of the gland function, and oral health-related quality of life (OHRQOL) as a patient-reported outcome measure (PROM) in a pSS cohort.</AbstractText><AbstractText Label="METHODS">Sixty-six patients with pSS were examined by SGUS according to Hocevar and Milic scoring systems. Patients with inhomogeneity/hypoechoic areas with scores ≥ 2 in parotid and submandibular glands were classified separately as "severe glandular involvement." Further, oral health, SFR, and Oral Health Impact Profile-14 (OHIP-14) for OHRQOL were assessed.</AbstractText><AbstractText Label="RESULTS">Both total Hocevar and Milic scores were higher in 21 pSS patients with low unstimulated whole salivary flow rate (U-WSFR) than 45 pSS patients without low U-WSFR (<i>P</i> = 0.001 and <i>P</i> < 0.0001, respectively). Increased scores of homogeneity, hypoechoic areas and glandular border visibility were observed in patients with low U-WSFR (<i>P</i> < 0.05). Among these variables, homogeneity score was found to be an independent risk factor for low U-WSFR in pSS according to logistic regression analysis (OR 1.586, <i>P</i> = 0.001). Moreover, a higher OHIP-14 score was observed in severe parotid involvement compared to nonsevere cases (23.26 ± 21.19 vs 8.32 ± 13.82, <i>P</i> = 0.004).</AbstractText><AbstractText Label="CONCLUSION">High Milic and Hocevar SGUS scores are associated with reduced SFR and poor OHRQOL as a PROM. The inhomogeneity component of the SGUS score is associated with low U-WSFR and is an indicator of severely affected gland function.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yalcinkaya</LastName><ForeName>Yasemin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Y. Yalcinkaya, Associate Professor, A. U. Ünal, MD, H. Direskeneli, Professor, N. Inanc, Professor, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mumcu</LastName><ForeName>Gonca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>G. Mumcu, Dentist, Professor, Department of Health Management, Marmara University School of Health Sciences, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Özdemir</LastName><ForeName>Filiz Türe</ForeName><Initials>FT</Initials><AffiliationInfo><Affiliation>F. Türe Özdemir, PhD, Division of Immunology, Marmara University, School of Medicine, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuruş</LastName><ForeName>Ramazan Esad</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>R. Esad Kuruş, MD, Marmara University, School of Medicine, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ünal</LastName><ForeName>Ali Uğur</ForeName><Initials>AU</Initials><AffiliationInfo><Affiliation>Y. Yalcinkaya, Associate Professor, A. U. Ünal, MD, H. Direskeneli, Professor, N. Inanc, Professor, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Direskeneli</LastName><ForeName>Haner</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Y. Yalcinkaya, Associate Professor, A. U. Ünal, MD, H. Direskeneli, Professor, N. Inanc, Professor, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruyn</LastName><ForeName>George A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>G.A. Bruyn, Professor, Department of Rheumatology, MC Groep Hospitals, Leystad, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inanc</LastName><ForeName>Nevsun</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Y. Yalcinkaya, Associate Professor, A. U. Ünal, MD, H. Direskeneli, Professor, N. Inanc, Professor, Division of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey; inanc.nevsun@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>J Rheumatol</MedlineTA><NlmUniqueID>7501984</NlmUniqueID><ISSNLinking>0315-162X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012463" MajorTopicYN="N">Saliva</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012469" MajorTopicYN="N">Salivary Glands</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012859" MajorTopicYN="Y">Sjogren's Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014463" MajorTopicYN="N">Ultrasonography</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Sjögren syndrome</Keyword><Keyword MajorTopicYN="Y">salivary glands</Keyword><Keyword MajorTopicYN="Y">ultrasonography</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>03</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32358157</ArticleId><ArticleId IdType="pii">jrheum.190849</ArticleId><ArticleId IdType="doi">10.3899/jrheum.190849</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Oman</li><li>Pays-Bas</li><li>Turquie</li></country></list><tree><country name="Turquie"><noRegion><name sortKey="Yalcinkaya, Yasemin" sort="Yalcinkaya, Yasemin" uniqKey="Yalcinkaya Y" first="Yasemin" last="Yalcinkaya">Yasemin Yalcinkaya</name></noRegion><name sortKey="Direskeneli, Haner" sort="Direskeneli, Haner" uniqKey="Direskeneli H" first="Haner" last="Direskeneli">Haner Direskeneli</name><name sortKey="Kuru, Ramazan Esad" sort="Kuru, Ramazan Esad" uniqKey="Kuru R" first="Ramazan Esad" last="Kuru">Ramazan Esad Kuru</name><name sortKey="Mumcu, Gonca" sort="Mumcu, Gonca" uniqKey="Mumcu G" first="Gonca" last="Mumcu">Gonca Mumcu</name><name sortKey="Ozdemir, Filiz Ture" sort="Ozdemir, Filiz Ture" uniqKey="Ozdemir F" first="Filiz Türe" last="Özdemir">Filiz Türe Özdemir</name><name sortKey="Unal, Ali U Ur" sort="Unal, Ali U Ur" uniqKey="Unal A" first="Ali U Ur" last="Ünal">Ali U Ur Ünal</name></country><country name="Pays-Bas"><noRegion><name sortKey="Bruyn, George A" sort="Bruyn, George A" uniqKey="Bruyn G" first="George A" last="Bruyn">George A. Bruyn</name></noRegion></country><country name="Oman"><noRegion><name sortKey="Inanc, Nevsun" sort="Inanc, Nevsun" uniqKey="Inanc N" first="Nevsun" last="Inanc">Nevsun Inanc</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SuicidDentistV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000050 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000050 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SuicidDentistV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32358157
|texte= Are Salivary Gland Ultrasonography Scores Associated with Salivary Flow Rates and Oral Health-related Quality of Life in Sjögren Syndrome?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32358157" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SuicidDentistV1
| This area was generated with Dilib version V0.6.39. |  |